Posted by Michael Wonder on 21 Apr 2020
DOJ clears U.S. drug companies to distribute hydroxychloroquine to coronavirus patients
21 April 2020 - The U.S. Department of Justice on Monday cited "extreme urgency" in clearing U.S. pharmaceutical distributors from legal hurdles in order to provide the controversial anti-malaria drug to coronavirus patients.
The Justice Department penned a response letter Monday notifying one of the country's largest wholesale drug distribution companies, AmerisourceBergen, that antitrust hurdles have been removed as part of an "expedited, temporary review procedure."
The DOJ letter dated April 20 says the drug corporation is now set to work with federal government agencies and health care providers to distribute hydroxychloroquine to patients with coronavirus symptoms.
